miR-150 in cancer metastasis: Orchestrating migration, invasion, and angiogenesis through context-dependent mechanisms
Cancer Treatment and Research Communications · 2025
DOI: 10.1016/j.ctarc.2025.101048 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Treatment and Research Communications, 2025. Verfasst von Belal Almajali und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Allied Medical Sciences, Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan. Electronic address: b…. Hauptthemen laut MEDLINE: MicroRNAs, Neovascularization, Pathologic, Neoplasms. Die Arbeit nennt 151 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Metastasis, which accounts for approximately 90 % of cancer-related mortality, is driven by intricate regulatory networks that remain only partially understood. MicroRNA-150 (miR-150) has emerged as a pivotal, context-dependent regulator within these networks, displaying dual functionality as either a tumor suppressor or an oncogene, depending on tumor type, isoform (-5p/-3p), and microenvironmental cues. This comprehensive review synthesizes evidence highlighting miR-150's regulation of critical metastatic processes-namely epithelial-mesenchymal transition, cell migration, invasion, extracellular matrix remodeling, and angiogenesis-through direct targeting of key molecular effectors and its dynamic integration into competitive endogenous RNA (ceRNA) networks involving long non-coding RNAs and circular RNAs. Notably, miR-150 primarily acts as a metastasis suppressor in solid tumors, such as breast, colorectal, and ovarian cancers, by inhibiting pro-metastatic signaling pathways. However, it paradoxically facilitates metastatic progression in specific contexts, including non-small cell lung cancer and cervical carcinoma, by activating oncogenic cascades through suppression of tumor suppressors. Clinically, reduced miR-150 expression serves as a robust indicator of advanced disease stage, lymph node involvement, and poor prognosis, while circulating exosomal miR-150 shows promise as a non-invasive diagnostic biomarker. Therapeutically, tailored strategies employing miR-150 mimics, antagomiRs, or ceRNA-targeted inhibitors hold potential for disrupting metastatic pathways; however, challenges such as isoform-specific targeting, precise delivery, and mitigation of off-target effects remain unresolved. In our view, framing miR-150 as a "double-edged sword" in metastatic regulation provides a conceptual framework for leveraging its molecular versatility to advance precision oncology and mitigate metastatic progression, particularly in combination with emerging systemic therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Allied Medical Sciences, Hourani Center for Applied Scientific Research, Al-Ahliyya Amman University, Amman, Jordan. Electronic address: b.almajali@ammanu.edu.jo.
- Department of Pharmacology and Toxicology, College of Pharmacy, Al Farahidi University, Baghdad, Iraq. Electronic address: waleedk.abdulsahib@uoalfarahidi.edu.iq.
- Department of Biotechnology and Genetics, School of Sciences, JAIN (Deemed to be University), Bangalore, Karnataka, India. Electronic address: j.renuka@jainuniversity.ac.in.
- Department of Medical Oncology, IMS and SUM Hospital, Siksha 'O' Anusandhan (Deemed to be University), Bhubaneswar, Odisha 751003, India. Electronic address: drpriya.sjh@gmail.com.
- Uttaranchal Institute of Pharmaceutical Sciences, Division of research and innovation, Uttaranchal University, Dehradun, Uttarakhand, India. Electronic address: ashishchauhan.pharmacy@gmail.com.
- Centre for Research Impact & Outcome, Chitkara University Institute of Engineering and Technology, Chitkara University, Rajpura, Punjab 140401, India. Electronic address: siyasingla0202@outlook.com.
Zitieren
APA
Almajali, B., Abdulsahib, W. K., Jyothi, S. R., Nayak, P. P., Chauhan, A. S., Singla, S., Mamedova, G., Sead, F. F., & Salajegheh, P. (2025). miR-150 in cancer metastasis: Orchestrating migration, invasion, and angiogenesis through context-dependent mechanisms. Cancer Treatment and Research Communications. https://doi.org/10.1016/j.ctarc.2025.101048
Vancouver
Almajali B, Abdulsahib WK, Jyothi SR, Nayak PP, Chauhan AS, Singla S, et al. miR-150 in cancer metastasis: Orchestrating migration, invasion, and angiogenesis through context-dependent mechanisms. Cancer Treatment and Research Communications. 2025. doi:10.1016/j.ctarc.2025.101048
BibTeX
@article{Almajali2025,
author = {Almajali, Belal and Abdulsahib, Waleed K and Jyothi, S Renuka and Nayak, Priya Priyadarshini and Chauhan, Ashish Singh and Singla, Siya and Mamedova, Guzalya and Sead, Fadhil Faez and Salajegheh, Pouria},
title = {miR-150 in cancer metastasis: Orchestrating migration, invasion, and angiogenesis through context-dependent mechanisms},
journal = {Cancer Treatment and Research Communications},
year = {2025},
doi = {10.1016/j.ctarc.2025.101048}
}
EUVIMED